Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 066381/0584 | |
| Pages: | 11 |
| | Recorded: | 01/30/2024 | | |
| Attorney Dkt #: | 41827-58333/US |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 056152 FRAME: 0989. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/09/2023
|
Application #:
|
17140664
|
Filing Dt:
|
01/04/2021
|
|
Publication #:
|
|
Pub Dt:
|
07/15/2021
| | | | |
|
Title:
|
COMBINATIONS OF ESTROGEN RECEPTOR DEGRADERS AND CYCLIN-DEPENDENT KINASE INHIBITORS FOR TREATING CANCER
|
|
|
Assignee
|
|
|
|
|
| 8 CLARKE DRIVE |
| SUITE 4 |
| CRANBURY, NEW JERSEY 41827 |
|
|
Correspondence name and address
|
| |
FENWICK & WEST LLP
|
| |
801 CALIFORNIA STREET
|
| |
MOUNTAIN VIEW, CA 94041
|
Search Results as of:
05/14/2024 06:45 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
